Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA)
Zantac lawsuit will have minimal impact on Teva Pharmaceutical''s financial position. Click here to read why TEVA stock is a Buy.
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA)
Zantac lawsuit will have minimal impact on Teva Pharmaceutical''s financial position. Click here to read why TEVA stock is a Buy.